The Latest Breaking News from CRVS

Momentum Is Just Starting for These 3 Rapid-Growth Stocks in 2026

Three standout stocks for 2026 have already generated massive returns of 56% or more this year, although they may cater to investors with a tolerance for risk.

MarketBeat · Feb 2

Recap: Corvus Pharmaceuticals Q4 Earnings

Corvus Pharmaceuticals (NASDAQ:CRVS) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · Mar 10, 2022